A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm (Q44024922)
scientific article
Language:
(P31) (Q13442814)
(P304) 1543-1555
(P407) (Q1860)
(P433) 9
(P478) 8
(P577) Saturday, September 1, 1990
(P921) (Q180507)
(Q5452194)
(Q42824440)
(Q181600)
(P1433) (Q400292)
(P1476) "A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm" (language: en)
(P2093) J D Cox
N Azarnia
R W Byhardt
K H Shin
B Emami
T F Pajak
other details
description scientific article

External Links